AbbVie Completes Acquisition of Nimble Therapeutics
3 days ago · For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube. Forward-Looking Statements . Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.
AbbVie and Neomorph Announce Collaboration to Develop …
3 days ago · "Protein degraders represent a groundbreaking advancement in the field of drug discovery and at AbbVie we are committed to advancing this technology forward," said Steven Elmore, vice president, small molecule therapeutics and platform technologies at AbbVie. "We are excited to collaborate with Neomorph to develop novel molecular glue degraders ...
AbbVie Completes Acquisition of Nimble Therapeutics - PR …
3 days ago · News provided by AbbVie Jan 23, 2025, 09:16 ET. Share this article. Share to X. Share this article. Share to X. Acquisition adds potential novel oral peptide IL23R inhibitor for psoriasis as well ...
AbbVie News Center - News
Jan 13, 2025 · AbbVie (NYSE: ABBV) will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. Management will participate in a fireside chat at 10:15 a.m. Central time. A... Looking for more news from AbbVie? Follow us on social media.
AbbVie Inc. (ABBV) Latest Stock News & Headlines - Yahoo Finance
Get the latest AbbVie Inc. (ABBV) stock news and headlines to help you in your trading and investing decisions.
AbbVie Provides Update on Phase 2 Results for Emraclidine in …
Nov 11, 2024 · AbbVie (NYSE: ABBV) today announced that its two Phase 2 EMPOWER trials investigating emraclidine as a once-daily, oral monotherapy treatment for adults with schizophrenia who are experiencing an...
AbbVie Raises 2024 Profit Forecast on Strong Sales of Key ... - U.S. News
Oct 30, 2024 · (Reuters) -AbbVie raised its annual profit forecast after strong sales of its newer immunology drugs and key cancer treatment helped the company beat Wall Street estimates for third-quarter...
AbbVie raises 2024 profit forecast on strong sales of key drugs …
Oct 30, 2024 · (Reuters) -AbbVie raised its annual profit forecast after strong sales of its newer immunology drugs and key cancer treatment helped the company beat Wall Street estimates for third-quarter...
AbbVie to Acquire Nimble Therapeutics, Further Strengthening …
Dec 13, 2024 · Additionally, AbbVie will acquire Nimble's peptide synthesis, screening, and optimization platform, which uses proprietary technology to help drive rapid discovery and optimization of peptide candidates for a range of targets.
AbbVie crafts $1.6B deal with molecular glue biotech Neomorph
3 days ago · AbbVie will pay the San Diego biotech an undisclosed upfront sum and offer up to $1.64 billion in option fees and milestones, plus royalties, according to a Jan. 23 release.